Stocks
Biomark Holdings IncBMIX
HealthcareBiotechnology
A development-stage biopharmaceutical company focused on acquiring and advancing innovative drug candidates. Its pipeline targets unmet medical needs in areas such as oncology and infectious diseases. Investors track the stock for its clinical milestones and potential licensing deals.
Congressional Interest in Biomark Holdings Inc (BMIX)
1 member of Congress has disclosed 1 trade in Biomark Holdings Inc (BMIX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading BMIX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-03-07 | MICHAEL T. MCCAUL | sell | $15K-$50K |